501-3292
Production Way, Burnaby, B.C., V5A 4R4
Phone:
(604) 551-7831 Fax: 604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
Cannabix
Technologies
Engages
MistyWest
-
Provides
Development
Update
on
Marijuana Breathalyzer
The Cannabix Marijuana Breathalyzer is being developed to give law
enforcement and employers a tool to enforce public safety.
Vancouver, British
Columbia -- November
15,
2018 -- InvestorsHub NewsWire -- Cannabix Technologies Inc. (CSE:
BLO) (OTC PINK: BLOZF) (the "Company or
Cannabix") developer of the
Cannabix Marijuana Breathalyzer for law enforcement and the
workplace, is pleased report that it has engaged a leading B.C.
based engineering and design
firm
for the development of a handheld breath collection device for its
marijuana breathalyzer unit. MistyWest Engineering of Vancouver has
begun work on a portable handheld device that will provide for easy
collection of breath samples at the point of care.
MistyWest is a
highly regarded engineering and design firm that has worked on
several high profile and innovative product development projects in
North America demonstrating the ability to complete projects
rapidly. Cannabix will use
the new handheld unit for the collection of multiple samples from
many users under a variety of conditions, quickly. The new breath
collection unit ("BCU") will provide key physiologic breath sample
data under different environmental conditions to determine the
effects such parameters on a 9-tetrahydrocannabinol ("THC") breath
sample. The device will be lightweight and include advanced display
capabilities as well as temperature, pressure and relative humidity
measurement capabilities. The BCU will be designed to collect
numerous samples required for pilot and research testing and be
easy to administer by untrained personnel. Furthermore, the BCU
will allow scientists to store samples and determine the effects of
decay time on the sample which is an important parameter in the
evidentiary process. It is estimated that the new handheld unit
will be ready by the end of this year. This BCU will interface
directly with the innovative FAIMS (field asymmetric
waveform ion mobility spectrometry) based instrument for the
detection of THC in human breath that Cannabix is
developing.
Dr. Raj
Attariwala stated, "We are pleased to
be working with a local firm MistyWest on the development of this
breath collection unit as it will aid in our ability to collect
multiple breath samples under various conditions to enhance our
capacity for sample collection, storage and handling. The engineers
at MistyWest have a lot of experience with human factor design and
creating these kinds of devices efficiently. This will integrate
with our added capacity for gas analysis using our new state of the
art equipment at our Florida facility."
The
Company also reports that it has recently expanded its lab space in
Gainesville, Florida and acquired an additional Thermo Scientific
GC mass spectrometer that is designed to analyze breath samples by
using the gold standard for gas analysis by
enabling thermal
desorption from sorbent tubes. In addition, Cannabix has added
additional electrical engineering staff in Vancouver.
About
Cannabix Technologies Inc.
Cannabix
Technologies Inc. is a leader in marijuana breathalyzer development
for law enforcement and the workplace. Cannabix has established
breath testing technologies in the pursuit of bringing durable,
portable hand-held tools to market to enhance detection of
marijuana impaired driving offences on roads at a time when
marijuana is becoming legal in many global jurisdictions. Cannabix
is working to develop drug-testing devices that will detect THC-
the psychoactive component of marijuana that causes intoxication-
using breath samples. In particular, Cannabix is focused on
developing breath testing devices for detection of recent use of
THC, in contrast to urine testing for THC metabolite that requires
an invasive collection and reflects usage,
days or
even weeks earlier. The devices will also be useful for other
practical applications such as testing employees in the workplace
where impairment
by THC
can be hazardous.
We seek
Safe Harbor.
On
behalf of the Board of Directors
"Rav
Mlait"
CEO
Cannabix
Technologies Inc.
For further information, contact the Company at
info@cannabixtechnologies.com
The
CSE has not reviewed and does not accept responsibility for the
adequacy or accuracy of this release.
Cautionary
Statement Regarding Forward-Looking Statements
This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company's plans and objectives to differ materially from
those expressed in the forward-looking information, including: (i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing "patent pending" technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.